BMRN
Closed
Biomarin Pharmaceutical Inc
56.19
+1.22 (+2.22%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 54.97
Day's Range: 54.625 - 56.66
Send
sign up or login to leave a comment!
When Written:
97.24
BioMarin Pharmaceutical Inc. is a biotechnology company headquartered in San Rafael, California, United States. The company was founded in 1997 and focuses on developing and commercializing therapies for rare genetic diseases. BioMarin's portfolio includes treatments for phenylketonuria (PKU), Batten disease, and hemophilia A and B. The company also has a pipeline of products in development for other rare diseases. BioMarin has operations in the United States, Europe, Latin America, and Asia. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol BMRN.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








